Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus

Demir S., Li J., Magder L. S., Petri M.

RHEUMATOLOGY, cilt.60, sa.8, ss.3770-3777, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 60 Sayı: 8
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1093/rheumatology/keaa857
  • Dergi Adı: RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
  • Sayfa Sayıları: ss.3770-3777
  • Anahtar Kelimeler: systemic lupus erythematosus, thrombosis, antiphospholipid antibodies, lupus anticoagulant, anticardiolipin, anti-beta 2-glycoprotein I, IgA isotype, INTERNATIONAL CONSENSUS STATEMENT, ANTICARDIOLIPIN ANTIBODIES, CLASSIFICATION CRITERIA, ANTI-BETA(2)-GLYCOPROTEIN I, CLINICAL-SIGNIFICANCE, DIAGNOSIS, ANTICOAGULANT, ASSOCIATION, MANIFESTATIONS, MORTALITY
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Objective. We evaluated which aPL combinations increase the risk of future thrombosis in patients with SLE.